DexCom Inc (DXCM)

Receivables turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	3,603,200	3,380,700	3,175,600	3,001,700	2,889,200	2,740,300	2,599,600	2,478,000	2,333,800	2,206,500	2,058,200	1,914,400	1,823,900	1,754,600	1,659,800	1,555,100	1,426,800	1,302,000	1,187,500	1,108,600
Receivables	US$ in thousands	987,500	788,500	755,600	652,500	752,200	597,100	612,000	544,500	514,300	529,100	483,500	443,400	428,500	370,000	296,500	300,700	286,300	234,900	217,300	204,700
Receivables turnover		3.65	4.29	4.20	4.60	3.84	4.59	4.25	4.55	4.54	4.17	4.26	4.32	4.26	4.74	5.60	5.17	4.98	5.54	5.46	5.42

December 31, 2023 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $3,603,200K ÷ $987,500K
= 3.65

The receivables turnover for Dexcom Inc has exhibited some fluctuations over the past eight quarters. It has ranged from a low of 3.67 in Q4 2023 to a high of 4.72 in Q1 2022. The trend shows a general stability in the turnover ratio, indicating that the company has been effectively managing its accounts receivable balance. A higher receivables turnover ratio signifies that the company is collecting its outstanding receivables more frequently within a given period, which can be indicative of efficient credit policies and diligent collection efforts. However, it is important to note that a very high receivables turnover ratio may also suggest overly stringent credit policies that could potentially hinder sales growth. Overall, Dexcom Inc's receivables turnover ratio over the period reflects reasonably efficient management of its accounts receivable.